Harmony Biosciences Holdings (HRMY) Cash & Equivalents (2019 - 2026)
Harmony Biosciences Holdings (HRMY) recorded Cash & Equivalents of $549.77 million in Q2 2026, up 0.7% from $546.05 million a year earlier but down 6.7% from the prior quarter.
Powered by 
Analysis
Harmony Biosciences Holdings (HRMY) Cash & Equivalents (2019 - 2026) Analysis & Trends
At the end of FY2025, Harmony Biosciences Holdings reported Cash & Equivalents of $752.5 million, up 66.1% from FY2024.
- Annual Cash & Equivalents has increased for six straight years, with a five-year compound annual growth rate of 26.9% (FY2020 to FY2025).
- Across earlier years, Cash & Equivalents came in at $453 million in FY2024 (+45.4%), $311.66 million in FY2023 (+27.8%), $243.78 million in FY2022 (+4.0%) and $234.31 million in FY2021 (+2.5%).
- Quarterly Cash & Equivalents has ranged from $189.7 million in Q3 2021 to $752.5 million in Q4 2025 over the past five years.
- On a year-over-year basis, Cash & Equivalents has increased for eight consecutive quarters, with growth averaging 42.2% over the last eight quarters.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 72.1% in Q2 2025, against a decline of 14.4% in Q3 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at $589.4 million (Q1 2026), $752.5 million (Q4 2025) and $647 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Harmony Biosciences Holdings | 2.30 Bn | -452.73 Mn | 198.08 Mn | 549.77 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 549.77 Mn |
| Mar 31, 2026 | 589.40 Mn |
| Dec 31, 2025 | 752.50 Mn |
| Sep 30, 2025 | 647.00 Mn |
| Jun 30, 2025 | 546.05 Mn |
| Mar 31, 2025 | 489.00 Mn |
| Dec 31, 2024 | 453.00 Mn |
| Sep 30, 2024 | 387.37 Mn |
| Jun 30, 2024 | 317.30 Mn |
| Mar 31, 2024 | 332.98 Mn |
| Dec 31, 2023 | 311.66 Mn |
| Sep 30, 2023 | 324.60 Mn |
| Jun 30, 2023 | 317.42 Mn |
| Mar 31, 2023 | 287.96 Mn |
| Dec 31, 2022 | 243.78 Mn |
| Sep 30, 2022 | 261.34 Mn |
| Jun 30, 2022 | 236.53 Mn |
| Mar 31, 2022 | 224.50 Mn |
| Dec 31, 2021 | 234.31 Mn |
| Sep 30, 2021 | 189.70 Mn |
API Access
Harmony Biosciences Holdings Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=HRMY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "HRMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=HRMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();